Prot# CZOL446H2301E1: A 3-Year, Double-Blind Extension to CZOL446H2301 to Evaluate the Long Term Safety and Efficacy of Zoledronic Acid in the Treatment of Osteoporosis in Post-Menopausal Women Taking Calcium and Vitamin D